Systimmune
SystImmune is a biopharmaceutical company focused on developing innovative cancer therapies, including bispecific antibodies and antibody-drug conjugates. They are seeking a Senior Scientist in Protein Engineering to lead research projects and contribute to the development of therapeutic antibodies in a dynamic environment.
Headquarters
Redmond, Washington, United States
Company Size
11-50 employees
Founded
2014
SystImmune is a Redmond, WA–based biopharmaceutical company developing bi‑specific and multi‑specific antibodies and antibody‑drug conjugates (ADCs) to treat cancer. Its mission is to create biologics that both directly attack tumors and activate the immune system to enhance anti‑tumor responses, using proprietary protein‑engineering and antibody‑discovery platforms. A multidisciplinary team across the U.S. and China focuses on rapid, cost‑efficient clinical development. SystImmune is a member of the Biokin Pharmaceutical group and partners with Bristol Myers Squibb and OrbiMed, and it is seeking additional collaborators to develop and commercialize its therapies worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Systimmune.
16% below the average for this role
Senior Scientist I (Protein & Antibody Production)
Exelixis
Associate Scientist/ Sr. Associate Scientist Antibody and Protein Engineering
Mediar Therapeutics
Associate Scientist, Antibody Sciences
immunomeinc
Research Scientist – Protein Sciences and Structural Biology
Elanco
Research Assistant – Schiffner Lab
The Wistar Institute
Senior Scientist, Antibody and Protein Engineering
Regeneron Pharmaceuticals